диссертации / 90

111

induces transcription of matrix metalloproteinases. // J. Immunol., 2001; 166(4),

p. 2801-2807.

102.van Bennekum A.M., Wei S., Gamble M.V., Vogel S., Piantedosi R., Gottesman M., Episkopou V., Blaner W.S. Biochemical basis for depressed serum retinol levels in transthyretin-deficient mice. // J. Biol. Chem., 2001; 276(2), p.11071113.

103.Vijg J, Suh Y. Genome instability and aging. Annu Rev Physiol. 2013;75:64568. doi: 10.1146/annurev-physiol-030212-183715.

104.Wamunyokoli F.W., Bonome T., Lee J.Y., Feltmate C.M., Welch W.R., Radonovich M., Pise-Masison C., Brady J., Hao K., Berkowitz R.S., Mok S., Birrer M.J. Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance. // Clin. Cancer Res., 2006; 12(3 Pt 1), p. 690-700.

105.Welsh P.L., King M.C. BRCA1 and BRCA2 and the genetics of breast of breast and ovarian cancer. Hum. Molec. Genet., 2001, Vol.10, p. 705-713.

106.White C.N., Zhang Z., Chan D.W. Quality control for SELDI analysis. // Clin. Chem. Lab. Med., 2005; 43(2):125-126.

107.Wolters S, Schumacher B. Genome maintenance and transcription integrity in aging and disease. Front Genet. 2013;4:19.

108.Wulfkuhle J.D., Liotta L.A., Petricoin E.F. Proteomic applications for the early detection of cancer. // Nat. Rev. Cancer., 2003; 3(4), p. 267-75. Review.

109.Xiao Z., Prieto D., Conrads T.P., Veenstra T.D., Issaq H.J. Proteomic patterns: their potential for disease diagnosis. // Mol. Cell. Endocrinol., 2005; 230(1-2), p. 95-106. Review.

110.Xu F.J., Yu Y.H., Daly L., Anselmino L., Hass G.M., Berchuck A., Rodriguez G.C., Soper J.T., Clarke-Pearson D.L., Hollis D., et al. OVX1 as a marker for early stage endometrial carcinoma. // Cancer, 1994; 73(7), p.1855-1858.

111.Xu L., Tan A.C., Naiman D.Q., Geman D., Winslow R.L. Robust prostate cancer marker genes emerge from direct integration of inter-study microarray data. // Bioinformatics, 2005; 21(20), p. 3905-3911.

112

112.Zhang X., Lu X., Shi Q., Xu X.Q., Leung H.C., Harris L.N., Iglehart J.D., Miron A., Liu J.S., Wong W.H. Recursive SVM feature selection and sample classification for mass-spectrometry and microarray data. // BMC Bioinformatics. 2006; 7:197.

113.Zhang Z., Barnhill S.D., Zhang H., Xu F., Yu Y., Jacobs I., Woolas R.P., Berchuck A., Madyastha K.R., Bast R.C. Jr. Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses. // Gynecol. Oncol., 1999; 73(1), p. 56-61.

114.Zhang Z., Bast R.C. Jr., Yu Y., Li J., Sokoll L.J., Rai A.J., Rosenzweig J.M., Cameron B., Wang Y.Y., Meng X.Y., Berchuck A., Van Haaften-Day C., Hacker N.F., de Bruijn H.W., van der Zee A.G., Jacobs I.J., Fung E.T., Chan D.W. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. // Cancer Res., 2004; 64(16), p. 58825890.

115.Zhou G., Li H., DeCamp D., Chen S., Shu H., Gong Y., Flaig M., Gillespie J.W., Hu N., Taylor P.R., Emmert-Buck M.R., Liotta L.A., Petricoin E.F. 3rd, Zhao Y. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. // Mol. Cell. Proteomics, 2002; 1(2), p. 117-124.